Literature DB >> 24274426

Primary cutaneous marginal zone lymphoma with sequential development of nodal marginal zone lymphoma in a patient with selective immunoglobulin A deficiency.

Marion Wobser1, Andreas Kerstan, Hermann Kneitz, Matthias Goebeler, Volker Kunzmann, Andreas Rosenwald, Eva Geissinger.   

Abstract

Multiple lymphoma subtypes occurring within one patient is rare in the context of B-cell lymphoma, and only few such cases have been reported in association with primary cutaneous marginal zone lymphoma (PCMZL). We herein describe the case of a 43-year-old patient who was diagnosed with PCMZL and subsequently developed a clonally unrelated nodal marginal zone lymphoma (MZL). At the time of diagnosis of PCMZL, multiple skin lesions were present. The atypical lymphoid infiltrate showed monotypic expression of immunoglobulin light chain lambda and heavy chain (IgM) on immunohistochemistry and an identical B-cell clone. No sign of systemic lymphoma was present in staging examinations. Complete remission was achieved utilizing rituximab. After a 3-year clinical course of repetitive cutaneous relapses and remissions, the patient additionally developed nodal lymphoma involvement by MZL which, however, harbored an immunophenotype and a genetic clone distinct from the cutaneous lymphoma counterpart. Therefore, the rare occurrence of two different types of MZL with sequential evolution was diagnosed. In this uncommon case, we hypothesize that selective immunoglobulin A deficiency may play a promoting role for the metachronous development of the two MZL that occurred in our patient.
© 2013 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  cancer research; cutaneous lymphomas; dermatopathology; immunocytochemistry

Mesh:

Year:  2013        PMID: 24274426     DOI: 10.1111/cup.12230

Source DB:  PubMed          Journal:  J Cutan Pathol        ISSN: 0303-6987            Impact factor:   1.587


  6 in total

1.  Lymphoma Secondary to Congenital and Acquired Immunodeficiency Syndromes at a Turkish Pediatric Oncology Center.

Authors:  Hikmet G Tanyildiz; Handan Dincaslan; Gulsan Yavuz; Emel Unal; Aydan Ikinciogulları; Figen Dogu; Nurdan Tacyildiz
Journal:  J Clin Immunol       Date:  2016-08-04       Impact factor: 8.317

Review 2.  Lymphoproliferation in Inborn Errors of Immunity: The Eye Does Not See What the Mind Does Not Know.

Authors:  Saniya Sharma; Rakesh Kumar Pilania; Gummadi Anjani; Murugan Sudhakar; Kanika Arora; Rahul Tyagi; Manpreet Dhaliwal; Pandiarajan Vignesh; Amit Rawat; Surjit Singh
Journal:  Front Immunol       Date:  2022-05-04       Impact factor: 8.786

Review 3.  Cancers Related to Immunodeficiencies: Update and Perspectives.

Authors:  Esmaeil Mortaz; Payam Tabarsi; Davod Mansouri; Adnan Khosravi; Johan Garssen; Aliakbar Velayati; Ian M Adcock
Journal:  Front Immunol       Date:  2016-09-20       Impact factor: 7.561

Review 4.  A Tumor Profile in Primary Immune Deficiencies Challenges the Cancer Immune Surveillance Concept.

Authors:  Daniel Satgé
Journal:  Front Immunol       Date:  2018-05-24       Impact factor: 7.561

Review 5.  Inborn Errors of Immunity and Cancer.

Authors:  Alessandra Tiri; Riccardo Masetti; Francesca Conti; Anna Tignanelli; Elena Turrini; Patrizia Bertolini; Susanna Esposito; Andrea Pession
Journal:  Biology (Basel)       Date:  2021-04-09

6.  A Systematic Review on Predisposition to Lymphoid (B and T cell) Neoplasias in Patients With Primary Immunodeficiencies and Immune Dysregulatory Disorders (Inborn Errors of Immunity).

Authors:  Irbaz Bin Riaz; Warda Faridi; Mrinal M Patnaik; Roshini S Abraham
Journal:  Front Immunol       Date:  2019-04-16       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.